AF
RVMD icon

Advisornet Financial’s Revolution Medicines RVMD Stock Holding History

Advisornet Financial’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.2K Buy
352
+38
+12% +$3.84K ﹤0.01% 1179
2025
Q4 		$25K Buy
314
+156
+99% +$10.2K ﹤0.01% 1260
2025
Q3 		$7.38K Buy
158
+133
+532% +$5.21K ﹤0.01% 1608
2025
Q2 		$920 Buy
+25
New +$960 ﹤0.01% 1956
2025
Q1 		– Sell
-6
Closed -$262 – 2235
2024
Q4 		$262 Buy
+6
New +$303 ﹤0.01% 1858
2024
Q1 		– Sell
-4
Closed -$115 – 2437
2023
Q4 		$115 Sell
4
-3
-43% -$72 ﹤0.01% 2353
2023
Q3 		$194 Buy
7
+4
+133% +$119 ﹤0.01% 2143
2023
Q2 		$80 Buy
3
+1
+50% +$25 ﹤0.01% 2287
2023
Q1 		$43 Buy
+2
New +$49 ﹤0.01% 2363

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Advisornet Financial's RVMD Position: Q1 2026 in Review

Advisornet Financial increased its Revolution Medicines (RVMD) stake by 12% in Q1 2026, buying an estimated $3.84K and bringing the position to 352 shares worth $34.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1179.

Advisornet Financial first reported a position in RVMD in Q1 2023 and has held it in 9 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Advisornet Financial held 352 shares of Revolution Medicines worth $34.2K as of Q1 2026.
  • Advisornet Financial bought 38 Revolution Medicines shares in Q1 2026, an estimated $3.84K.
  • Revolution Medicines made up ﹤0.01% of Advisornet Financial's portfolio in Q1 2026, its #1179 holding.
  • Advisornet Financial first reported a position in Revolution Medicines in Q1 2023 and has held it in 9 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Advisornet Financial's 13F filing for Q1 2026, filed 17 Apr 2026.